Chicago, IL, United States of America

Masanori Fukui


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Invention of Antibiotic Tetronolide Compounds by Masanori Fukui

Introduction

Masanori Fukui is an accomplished inventor based in Chicago, Illinois, known for his significant contributions to the field of microbiology and antibiotic development. His pioneering work has led to the creation of innovative antibiotic tetronolide compounds that have the potential to combat bacterial infections.

Latest Patents

Fukui holds a patent for his invention titled "Antibiotics tetronolide compounds and process for production thereof." The patent describes the production of new antibacterial tetronolide compounds, specifically F-1 and F-2, through the fermentation of a microorganism from the genus Micromonospora. The process involves isolating these antibiotics from the culture liquor and synthesizing various acyl derivatives, including F-1-21-O-acetate, F-1-21-O-propionate, F-1-21-O-n-butylate, F-1 diacetate, F-1 dipropionate, F-2 triacetate, F-2 tripropionate, and F-2 tri-n-butylate using established methods.

Career Highlights

Masanori Fukui works for Kyowa Hakko Kogyo Co., Ltd., a company recognized for its innovations in biopharmaceuticals and biotechnology. His research and expertise in antibiotics have positioned him as a key figure in the development of effective treatments against resistant bacterial strains.

Collaborations

Throughout his career, Fukui has collaborated with various prominent researchers, including Fusao Tomita and Tatsuya Tamaoki. These collaborations have enriched his research pursuits and expanded the scope of his inventions, further enhancing the impact of his work in the field of antibiotics.

Conclusion

Masanori Fukui's contributions to antibiotic research through his invention of tetronolide compounds underscore the importance of innovation in combating bacterial infections. His work exemplifies how collaborative efforts within research institutions can lead to groundbreaking advancements in healthcare and promote continued progress in the development of effective antibiotic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…